Questionable tolerability of tiagabine in generalized anxiety disorder.
Spielmans
Glen I
GI
D014151:Anti-Anxiety Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D009557:Nipecotic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D000078308:Tiagabine
D014151:Anti-Anxiety Agents; D009557:Nipecotic Acids; D000078308:Tiagabine